Combigan Interactions
There are 548 drugs known to interact with Combigan (brimonidine/timolol ophthalmic), along with 12 disease interactions, and 1 alcohol/food interaction. Of the total drug interactions, 29 are major, 515 are moderate, and 4 are minor.
- View all 548 medications that may interact with Combigan
- View Combigan alcohol/food interactions (1)
- View Combigan disease interactions (12)
Most frequently checked interactions
View interaction reports for Combigan (brimonidine / timolol ophthalmic) and the medicines listed below.
- amlodipine
- aspirin
- Aspirin Low Strength (aspirin)
- atorvastatin
- Azopt (brinzolamide ophthalmic)
- dorzolamide ophthalmic
- Fish Oil (omega-3 polyunsaturated fatty acids)
- furosemide
- gabapentin
- hydrochlorothiazide
- latanoprost ophthalmic
- levothyroxine
- lisinopril
- losartan
- Lumigan (bimatoprost ophthalmic)
- metformin
- metoprolol
- multivitamin
- omeprazole
- pantoprazole
- prednisone
- rosuvastatin
- simvastatin
- tamsulosin
- tramadol
- Travatan Z (travoprost ophthalmic)
- Tylenol (acetaminophen)
- Vitamin B12 (cyanocobalamin)
- Vitamin C (ascorbic acid)
- Vitamin D3 (cholecalciferol)
Combigan alcohol/food interactions
There is 1 alcohol/food interaction with Combigan (brimonidine / timolol ophthalmic).
Combigan disease interactions
There are 12 disease interactions with Combigan (brimonidine / timolol ophthalmic) which include:
- asthma/COPD
- bradycardia/AV block
- cardiogenic shock
- CHF
- diabetes
- hypersensitivity
- hyperthyroidism
- PVD
- cardiovascular
- depression
- renal/liver
- myasthenia gravis
Report options
More about Combigan (brimonidine / timolol ophthalmic)
- Combigan consumer information
- Compare alternatives
- Pricing & coupons
- Reviews (25)
- Side effects
- Dosage information
- During pregnancy
- Generic availability
- FDA approval history
- Drug class: ophthalmic glaucoma agents
- En español
Related treatment guides
Drug Interaction Classification
| Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit. | |
| Moderately clinically significant. Usually avoid combinations; use it only under special circumstances. | |
| Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan. | |
| No interaction information available. |
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.